JBC Origene Your Gene Company

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Firestein, R.
Right arrow Articles by Feuerstein, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Firestein, R.
Right arrow Articles by Feuerstein, N.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 273, Issue 10, 5892-5902, March 6, 1998

Association of Activating Transcription Factor 2 (ATF2) with the Ubiquitin-conjugating Enzyme hUBC9
IMPLICATION OF THE UBIQUITIN/PROTEASOME PATHWAY IN REGULATION OF ATF2 IN T CELLS

Ron Firestein and Nili Feuerstein

From the Center for Gerontology, Allegheny University of the Health Sciences and the Division of Rheumatology, Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104

Activating transcription factor 2 (ATF2) is regulated by phosphorylation via the Jun N-terminal kinase, and its binding activity is markedly induced at late stages of T and B lymphocyte activation (Feuerstein, N., Firestein, R., Aiyer, N., Xiao, H., Murasko, D., and Cristofalo, V. (1996) J. Immunol. 156, 4582-4593). To identify proteins that interact specifically with ATF2 in lymphocytes, the yeast two-hybrid interaction system was employed using ATF2 cDNA as a "bait." In two separate screenings, a clone was identified that revealed a novel sequence with homology to several members of the ubiquitin-conjugating enzyme family. An identical sequence was recently reported as the human homolog of the yeast UBC9, hUBC9. Northern blot analysis revealed a 1.3-kilobase RNA transcript, which showed differential levels of expression in various human tissues and a moderate induction after a 48-h stimulation of peripheral blood T lymphocytes. An antibody that was generated against the bacterially expressed glutathione S-transferase-hUBC9 detected a ~19-kDa protein, which localizes predominantly in the nuclei of T cells. Further quantitative assays using the yeast two-hybrid system confirmed a high and specific level of interaction of hUBC9 with ATF2 and lack of interaction with lamin or control vectors. Two other cyclic AMP-responsive element-binding transcription factors, CREB and ATF1, also showed significant levels of interaction with hUBC9. However, this interaction was severalfold lower as compared with ATF2. Far Western blot analysis confirmed the specific binding of ATF2 and hUBC9 also in vitro. Evidence is presented that indicates a physiological significance for the interaction of hUBC9 with ATF2. (a) We show that ATF2 is ubiquitinated in vivo and in vitro, and (b) ATF2 ubiquitination in vitro is facilitated by addition of purified hUBC9. (c) ATF2 is shown to undergo a proteolytic process, which is rapidly regulated upon T cell activation concomitant with induction of ATF2 phosphorylation. (d) A proteasome inhibitor delays the down-regulation of ATF2 phophorylation after T cell activation. Taken collectively, these results implicate a role for hUBC9 and the ubiquitin/proteasome pathway in regulation of ATF2 in T cells.


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
A. Bhoumik, N. Singha, M. J. O'Connell, and Z. A. Ronai
Regulation of TIP60 by ATF2 Modulates ATM Activation
J. Biol. Chem., June 20, 2008; 283(25): 17605 - 17614.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. L. Lawrence, H. Maekawa, J. L. Worthington, W. Reiter, C. R. M. Wilkinson, and N. Jones
Regulation of Schizosaccharomyces pombe Atf1 Protein Levels by Sty1-mediated Phosphorylation and Heterodimerization with Pcr1
J. Biol. Chem., February 23, 2007; 282(8): 5160 - 5170.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. Gaikwad, A. Poblenz, V. Haridas, C. Zhang, M. Duvic, and J. Gutterman
Triterpenoid Electrophiles (Avicins) Suppress Heat Shock Protein-70 and X-Linked Inhibitor of Apoptosis Proteins in Malignant Cells by Activation of Ubiquitin Machinery: Implications for Proapoptotic Activity
Clin. Cancer Res., March 1, 2005; 11(5): 1953 - 1962.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Sevilla, C. R. Santos, F. M. Vega, and P. A. Lazo
Human Vaccinia-related Kinase 1 (VRK1) Activates the ATF2 Transcriptional Activity by Novel Phosphorylation on Thr-73 and Ser-62 and Cooperates with JNK
J. Biol. Chem., June 25, 2004; 279(26): 27458 - 27465.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
N. Feuerstein, D. Shivers, F. Chen, R. A. Eisenberg, and T. H. Finkel
Chronic GVH prevents anergy in bone marrow self-reactive B cells: a selective increase in post-endoplasmic reticulum processing and trafficking to the cell surface of autoreactive IgM receptors
Int. Immunol., August 1, 2003; 15(8): 975 - 985.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. M. Comerford, M. O. Leonard, J. Karhausen, R. Carey, S. P. Colgan, and C. T. Taylor
Small ubiquitin-related modifier-1 modification mediates resolution of CREB-dependent responses to hypoxia
PNAS, February 4, 2003; 100(3): 986 - 991.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Saitoh, M. D. Pizzi, and J. Wang
Perturbation of SUMOlation Enzyme Ubc9 by Distinct Domain within Nucleoporin RanBP2/Nup358
J. Biol. Chem., February 8, 2002; 277(7): 4755 - 4763.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
S. Bellanger, C. Demeret, S. Goyat, and F. Thierry
Stability of the Human Papillomavirus Type 18 E2 Protein Is Regulated by a Proteasome Degradation Pathway through Its Amino-Terminal Transactivation Domain
J. Virol., August 15, 2001; 75(16): 7244 - 7251.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
I. Lassot, E. Ségéral, C. Berlioz-Torrent, H. Durand, L. Groussin, T. Hai, R. Benarous, and F. Margottin-Goguet
ATF4 Degradation Relies on a Phosphorylation-Dependent Interaction with the SCF{beta}TrCP Ubiquitin Ligase
Mol. Cell. Biol., March 15, 2001; 21(6): 2192 - 2202.
[Abstract] [Full Text]


Home page
Int ImmunolHome page
A. M. Reimold, J. Kim, R. Finberg, and L. H. Glimcher
Decreased immediate inflammatory gene induction in activating transcription factor-2 mutant mice
Int. Immunol., February 1, 2001; 13(2): 241 - 248.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. T. Taylor, G. T. Furuta, K. Synnestvedt, and S. P. Colgan
Phosphorylation-dependent targeting of cAMP response element binding protein to the ubiquitin/proteasome pathway in hypoxia
PNAS, October 12, 2000; (2000) 220211797.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
S. Y. Fuchs, I. Tappin, and Z.'e. Ronai
Stability of the ATF2 Transcription Factor Is Regulated by Phosphorylation and Dephosphorylation
J. Biol. Chem., April 21, 2000; 275(17): 12560 - 12564.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. Feuerstein, F. Chen, M. Madaio, M. Maldonado, and R. A. Eisenberg
Induction of Autoimmunity in a Transgenic Model of B Cell Receptor Peripheral Tolerance: Changes in Coreceptors and B Cell Receptor-Induced Tyrosine-Phosphoproteins
J. Immunol., November 15, 1999; 163(10): 5287 - 5297.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Tintut, F. Parhami, V. Le, G. Karsenty, and L. L. Demer
Inhibition of Osteoblast-specific Transcription Factor Cbfa1 by the cAMP Pathway in Osteoblastic Cells. UBIQUITIN/PROTEASOME-DEPENDENT REGULATION
J. Biol. Chem., October 8, 1999; 274(41): 28875 - 28879.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. S. Huggins, M. T. Chin, N. E. S. Sibinga, S.-L. Lee, E. Haber, and M.-E. Lee
Characterization of the mUBC9-binding Sites Required for E2A Protein Degradation
J. Biol. Chem., October 1, 1999; 274(40): 28690 - 28696.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Poukka, P. Aarnisalo, U. Karvonen, J. J. Palvimo, and O. A. Janne
Ubc9 Interacts with the Androgen Receptor and Activates Receptor-dependent Transcription
J. Biol. Chem., July 2, 1999; 274(27): 19441 - 19446.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. R. Chakrabarti, R. Sood, S. Ganguly, S. Bohlander, Z. Shen, and G. Nucifora
Modulation of TEL transcription activity by interaction with the ubiquitin-conjugating enzyme UBC9
PNAS, June 22, 1999; 96(13): 7467 - 7472.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S. Y. Fuchs and Z.'e. Ronai
Ubiquitination and Degradation of ATF2 Are Dimerization Dependent
Mol. Cell. Biol., May 1, 1999; 19(5): 3289 - 3298.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. S. Rodriguez, C. Dargemont, and R. T. Hay
SUMO-1 Conjugation in Vivo Requires Both a Consensus Modification Motif and Nuclear Targeting
J. Biol. Chem., April 13, 2001; 276(16): 12654 - 12659.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. V. Ivanova, S. V. Ivanov, A. Danilkovitch-Miagkova, and M. I. Lerman
Regulation of STRA13 by the von Hippel-Lindau Tumor Suppressor Protein, Hypoxia, and the UBC9/Ubiquitin Proteasome Degradation Pathway
J. Biol. Chem., April 27, 2001; 276(18): 15306 - 15315.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. T. Taylor, G. T. Furuta, K. Synnestvedt, and S. P. Colgan
Phosphorylation-dependent targeting of cAMP response element binding protein to the ubiquitin/proteasome pathway in hypoxia
PNAS, October 24, 2000; 97(22): 12091 - 12096.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.